Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The SURPASS-2 study included a total of 1878 patients with T2D who were receiving a background of metformin therapy, with an HbA1c of 7.0% to 10.5%, and were randomized to one of the four treatment arms
Doctor-Guided Medical Weight Loss Learn how prescription GLP-1 medications like semaglutide or tirzepatide may support weight loss when guided by a licensed medical provider and tailored to your health history
In mouse models, infusion of GIP was found to have anti-atherogenic effects
Key results from Calocurb's fourth human clinical study include the following: Calocurb is clinically shown to improve body composition by reducing body fat without losing muscle mass Average weight loss of 8.3 lbs (3.77 kg) after six months, compared to 0.88 lbs (0.4 kg) with the placebo group Over 6.5x greater reduction in body fat vs placebo Average body fat loss of 9.9 lbs (4.49 kg) vs 1.5 lbs (0.68 kg) after six months of consistent use of Calocurb vs placebo 3.5x greater reduction in visceral fat vs placebo Average visceral fat loss of 5 in2 (32.5 cm2) vs 1.4 in2 (9.1 cm2) lost after six months of consistent use of Calocurb vs placebo For over a decade, Calocurb has undertaken ground-breaking clinical research into Amarasate to continue bringing natural weight management solutions to those interested in GLP-1 and weight loss options.
Known for its incredible glutathione skin lightening abilities, this melanin inhibitor injection works from the inside outnaturally evening skin tone and reducing dark spots
US$ 28.33
US$ 29.17
US$ 20.58
US$ 21.47
US$ 21.66
